Hospital del Mar Research Institute Hospital del Mar Research Institute

News

27/10/2022 - General information

The College of Pharmacists of Barcelona awards the CARGENCORS study

On the occasion of the Pharmacist's Day, last October 18, the Barcelona College of Pharmacists awarded the Prize for the best community project in the CARGENCORS Study: Cardiovascular Genetic risk score for Risk Stratification of patients positive for the SARS-CoV-2 (COVID-19) virus, led by researchers and physicians from the Hospital del Mar Medical Research Institute (IMIM), the Institute of Biomedical Research of Girona. Josep Trueta (IDIBGI), the University Institute for Primary Care Research (IDIAP Jordi Gol) and the University of Vic-Central University of Catalonia.

CARGENCORS is based on the fact that coronaviruses affect the cardiovascular system. Several studies point to higher levels of mortality in patients with COVID-19 who had previous cardiovascular risk factors.

This study will analyze whether genetic predisposition to coronary risk can be used as a prognostic element of severity in patients with COVID-19 so researchers will analyze a set of 50 genetic variables associated with cardiovascular disease, risk of inflammation and risk of thrombosis in samples from 3000 patients.

The researcher Anna Camps collected the award on behalf of the authors: Anna Camps Vilaró, Jaime Marrugat, Irene Román Dégano, Isaac Subirana Cachinero, Rafel Ramos Blanes, Roberto Elosua, Claudia Solà Richarte, Mellina Pinsach Abuin, Ramon Brugada Terradellas, Ruth Martí Lluch.

Related information

More news

© Institut Hospital del Mar
d'Investigacions Mèdiques
Legal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact